Tel: +49 6172 686-0
About Fresenius Kabi
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company’s products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems.
31 articles with Fresenius Kabi
Fresenius Kabi announced it is introducing smart labels for a range of essential medications used in hospitals.
CORRECTING and REPLACING Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine
The date under the "Expiration Date" column for the row associated with Batch Number 6122207 should read: 06/2021.
Premier Inc. ProvideGx™ Program Partners with Fresenius Kabi to Secure the Supply of Sedation Drug Essential for COVID-19 Care
Premier Inc., through its ProvideGx™ program, has partnered with Fresenius Kabi to supply Diprivan® injectable emulsion, USP to healthcare providers, helping to stabilize the long-term supply of a medication vital for COVID-19 patient care.
Fresenius Kabi Expands MicroVault® Packaging to include Simplist® Morphine Sulfate Injection, USP Ready-to-Administer Prefilled Syringes
Fresenius Kabi Expands MicroVault ® Packaging to include Simplist ® Morphine Sulfate Injection, USP Ready-to-Administer Prefilled Syringes
Sedative that Received FDA Emergency Use Authorization Now Available from Fresenius Kabi for use in Mechanically Ventilated COVID-19 patients
Sedative that Received FDA Emergency Use Authorization Now Available from Fresenius Kabi for use in Mechanically Ventilated COVID-19 patients FDA authorization allows importation of Propoven 2% (propofol 20 mg per mL), double the concentration of the widely used drug Diprivan ® COVID-19 patients requiring mechanical ventilation increased demand for propofol worldwide LAKE ZURICH, Ill.--( BUSINESS WIRE )-- Fresenius Kabi announced today t
Pegfilgrastim is used to fight infection in patients undergoing chemotherapy by stimulating the body’s production of white blood cells Fresenius Kabi’s first U.S. biosimilar candidate
First-to-market generic for Mycamine ® provides cost-effective option Creates additional anti-infective supply for customers LAKE ZURICH, Ill.--( BUSINESS WIRE )-- Fresenius Kabi announced today the immediate availability in the United States of Micafungin for Injection. Fresenius Kabi’s Micafungin for Injection is available in 50 mg and 100 mg strengths in a 10 mL vial. This press release features multimedia. View the full release here: https
CORRECTING and REPLACING CAPTIONS Fresenius Kabi Issues Voluntary Nationwide Recall of 13 Lots of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter in Reserve Samples
Fresenius Kabi USA, LLC is voluntarily recalling Ketorolac Tromethamine Injection, USP, 60 mg/2 mL, 2 mL fill in a 2 mL amber vial to the user level due to the presence of particulate matter.
Partnership brings together Vifor Pharma’s world-class iron deficiency portfolio with Fresenius Kabi’s market-leading patient access in China
A New Expert Consensus Publication Provides Practical Guidance on the Use of Omega-3 Fatty Acids in Parenteral Nutrition
Fresenius Kabi announces that the Journal of Parenteral and Enteral Nutrition has recently published "Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice". The publication represents the largest set of expert consensus statements to provide guidance on the use of fish oil-containing lipid emulsions in clinical practice.
Fresenius Kabi Introduces Glucagon Emergency Medicine Kit to Treat Life-Threatening Episodes of Low Blood Sugar
Feb. 5, 2020 14:00 UTC Glucagon Emergency Kit is a cost-effective alternative to currently marketed branded kit products for severe hypoglycemia
Alternative to BENTYL® treats functional bowel and irritable bowel syndrome
Fresenius Kabi Expands Anti-Infective Portfolio with Launch of Ertapenem for Injection in 1 Gram Vial Presentation
The new product is the generic equivalent to Ivanz®.
Vizient announced it has signed an agreement with Fresenius Kabi to supply six critical care drugs under Vizient’s successful Novaplus private label pharmacy program.
Alternative to Emend® prevents nausea and vomiting associated with moderately and highly emetogenic chemotherapy in adult patients
Fresenius Kabi announced today the immediate availability in the United States of Phenylephrine Hydrochloride Injection, USP.
Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Fluorouracil Injection Due to the Potential for Glass Particulate
Fresenius Kabi USA, LLC is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL, 100mL fill in 100mL vials, to the user level due to the potential for glass particulate.
Fresenius Kabi Introduces Neostigmine Methylsulfate Injection, USP Simplist® Prefilled Syringe in 3 mg per 3 mL Presentation
Common concentration now available exclusively in FDA-approved ready-to-administer prefilled syringe
Premier’s ProvideGx™ Subsidiary and Fresenius Kabi Collaborate to Address Drug Shortages for Five Critical Medications
ProvideGx, LLC, a consolidated subsidiary of Premier Inc. and a healthcare improvement company developing a more stable and reliable supply chain for generic drugs in short supply, is collaborating with Fresenius Kabi to help mitigate national shortages of injectable thiamine, lidocaine, diphenhydramine, hydromorphone and morphine sulfate.
The United Food and Commercial Workers Local 1500 (UFCW Local 1500) filed a class action lawsuit against AbbVie for allegedly using a group of patents to maintain a monopoly on its blockbuster Humira (adalimumab).